Skip to content
DeepViews

Pro-Dex Inc New (PDEX) — Analysis Summary

Pro-Dex Inc New (PDEX) has a market cap of $199.72M with year-over-year revenue growth of +23.7%. Net margin stands at 13.5%. The stock trades at a P/E ratio of 16.6.

Key Takeaways

  • Revenue changed +23.7% year-over-year
  • Net margin of 13.5%
  • P/E ratio of 16.6

Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, PDEX posted revenue growth of +23.7% and trades at a P/E of 16.6.

[XNAS]

Pro-Dex Inc New (PDEX)

$62.55

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$199.72M
Enterprise Value
$214.84M
P/E Ratio
16.6
Div Yield
0.00%
EV/EBITDA
17.7
Company Profile
About
About Pro-Dex Inc New

Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.

Sector

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Employees

181

Headquarters

IRVINE, CA

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
65
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$45.20M
Total Debt$22.73M
Debt-to-Equity0.50
Cash & Equivalents$6.63M

Cash Flow

Operating Cash Flow$7.34M
Free Cash Flow$0.00M
FCF Margin0.00%
P/FCF RatioN/A
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.